Somatostatin analogs and hepatocellular carcinoma: Not dead yet?
Raftery
Laura
L
Division of Hematology and Oncology, University of North Carolina School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. lraftery@unch.unc.edu
O'Neil
Bert H
BH
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008297:Male; D015282:Octreotide / Q000627:therapeutic use; D011877:Radionuclide Imaging / Q000379:methods; D013004:Somatostatin / Q000031:analogs & derivatives*
D018931:Antineoplastic Agents, Hormonal; D013004:Somatostatin; D015282:Octreotide